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Incidence of Non-Hodgkin’s Lymphoma (NHL) remains
high in the context of HIV infection. High-grade NHL
are the sub-types commonly seen. Indolent lymphomas
have been rarely described although several cases of fol-
licular or marginal zone lymphoma (MZL) have been
published. Among MZL, MALT lymphomas are predo-
minant. We describe 3 cases of MZL with leukemic
presentation.
In our on-going cohort of 580 HIV-patients, 3 cases of
MZL were identified. The following characteristic were
recorded: clinical exam, thoracoabdominal CT-scan,
cytological aspect of the peripheral blood smear, immu-
nologic and cytogenetic analysis.
There were 2 male and 1 female. Duration of HIV
infection was 8, 13 and 18 when MZL was diagnosed.
HCV serology was positive in 2 cases with pcr negativ-
ity in one case. In all cases, MZL was diagnosed during
the occurrence of a mild hyperlymphocytosis: 5000,
6000 and 9000/mm3 respectively while hemoglobin
and platelets remained normal. All patients were
received HAART for more than 8 years and all have
CD4 above 500/mm3 and viral load under 50 copies/
ml. All patients were asymptomatic without peripheral
adenopathy neither hepatosplenomegaly. On thora-
coabdominal CT scan, only infracentrimetric adenopa-
thy were detected. On peripheral smears, several
lymphocytes with a villous aspect were detected for
each patient. In all cases, immunologic phenotype by
FACS was consistent with the diagnosis of MZL. Kar-
yotype of the peripheral lymphocytes was normal in
one case, revealed an isochromosome 3 in the second
case and showed 46, XX, der(1)t(1;?), t(8;14;18)(q24;
q32;q21) in the last case. After a follow-up of 2, 2 and
5 years, all patients are alive with a stable disease with-
out chemotherapy.
These data suggest that, as for non-HIV infected
patients, MZL have an indolent course in HIV patients.
Published: 25 May 2012
doi:10.1186/1742-4690-9-S1-P135
Cite this article as: Genet et al.: Marginal zone lymphomas in HIV
patients. Retrovirology 2012 9(Suppl 1):P135.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit * Correspondence: philippe.genet@ch-argenteuil.fr
Hématologie at Centre Hospitalier Victor Dupouy, Argenteuil, France
Genet et al. Retrovirology 2012, 9(Suppl 1):P135
http://www.retrovirology.com/content/9/S1/P135
© 2012 Genet et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.